ABT:NYE-Abbott Laboratories

EQUITY | Medical Devices | New York Stock Exchange

Last Closing

USD 71.42

Change

0.00 (0.00)%

Market Cap

USD 56.45B

Volume

9.40M

Analyst Target

USD 79.58
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-01-20 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SYK Stryker Corporation

-0.84 (-0.23%)

USD 134.32B
MDT Medtronic PLC

+0.23 (+0.26%)

USD 111.01B
BSX Boston Scientific Corp

-0.13 (-0.19%)

USD 100.86B
EW Edwards Lifesciences Corp

+0.41 (+0.43%)

USD 51.24B
ZBH Zimmer Biomet Holdings Inc

-0.63 (-0.48%)

USD 25.43B
STE STERIS plc

-0.70 (-0.31%)

USD 23.00B
SNN Smith & Nephew SNATS Inc

-0.98 (-3.72%)

USD 11.55B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 9.88B
BIO Bio-Rad Laboratories Inc

-3.69 (-1.06%)

USD 9.78B
PEN Penumbra Inc

-3.20 (-1.41%)

USD 8.60B

ETFs Containing ABT

UMDV:SW iShares US Medical Device.. 17.51 % 0.00 %

+0.09 (+0.09%)

USD 0.18B
EDOC:AU BetaShares Digital Health.. 8.61 % 0.00 %

+0.07 (+0.09%)

N/A
HART IQ Healthy Hearts ETF 5.40 % 0.00 %

+0.04 (+0.09%)

USD 9.64M
ZWHC:CA BMO Covered Call Health C.. 4.77 % 0.00 %

-0.05 (0.09%)

CAD 0.01B
XGES:LSE Xtrackers MSCI Genomic He.. 4.73 % 0.00 %

+0.22 (+0.09%)

USD 3.60M
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.66 % 0.00 %

+0.26 (+0.09%)

USD 3.60M
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.63 % 0.00 %

+0.25 (+0.09%)

USD 0.15B
IUAE:CA Invesco S&P US Dividend A.. 4.29 % 0.00 %

+0.18 (+0.09%)

CAD 1.08M
DXSB:F Xtrackers - Stoxx Global .. 4.14 % 0.00 %

N/A

USD 0.56B
DXSB:XETRA Xtrackers - Stoxx Global .. 4.14 % 0.00 %

+0.24 (+0.09%)

USD 0.68B
XGSD:SW Xtrackers Stoxx Global Se.. 4.14 % 0.00 %

+0.07 (+0.09%)

USD 0.58B
XGSD:XETRA Xtrackers Stoxx Global Se.. 4.14 % 0.00 %

+0.24 (+0.09%)

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.77 % 0.00 %

+0.20 (+0.09%)

USD 0.39B
SXLV:SW SPDR S&P U.S. Health Care.. 3.77 % 0.00 %

+0.34 (+0.09%)

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.77 % 0.00 %

+0.08 (+0.09%)

USD 2.24B
XUHC:SW Xtrackers MSCI USA Health.. 3.66 % 0.00 %

+0.05 (+0.09%)

USD 1.04B
WELG:XETRA Amundi S&P Global Health .. 3.43 % 0.00 %

+0.08 (+0.09%)

USD 0.25B
WELS:XETRA Amundi S&P Global Health .. 3.43 % 0.00 %

+0.08 (+0.09%)

USD 0.25B
DIP ETF Series Solutions 3.34 % 0.00 %

+0.15 (+0.09%)

USD 1.04M
AIVL WisdomTree Trust - Wisdom.. 3.09 % 0.00 %

+0.30 (+0.09%)

USD 0.38B
HEAL:CA 2.82 % 0.00 %

N/A

N/A
CGDV Capital Group Dividend Va.. 2.70 % 0.00 %

-0.08 (0.09%)

USD 6.73B
CGUS Capital Group Core Equity.. 2.48 % 0.00 %

-0.07 (0.09%)

USD 2.32B
OALC Unified Series Trust 1.96 % 0.00 %

-0.01 (0.09%)

USD 0.10B
HYLG Global X Funds - Global X.. 1.73 % 0.00 %

+0.04 (+0.09%)

USD 2.75M
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

+0.09 (+0.09%)

USD 1.41M
CWS AdvisorShares Focused Equ.. 0.00 % 0.68 %

+0.46 (+0.09%)

USD 0.14B
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

+0.06 (+0.09%)

USD 3.19B
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

+0.08 (+0.09%)

USD 5.45B
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.09 (+0.09%)

USD 4.00B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

N/A

USD 3.48B
JHMH 0.00 % 0.46 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

-0.12 (0.09%)

USD 0.29B
PWV Invesco Dynamic Large Cap.. 0.00 % 0.55 %

+0.31 (+0.09%)

USD 0.84B
QDYN 0.00 % 0.37 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

+0.22 (+0.09%)

USD 4.86B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.08B
RWDC 0.00 % 0.00 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

+0.05 (+0.09%)

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

+0.26 (+0.09%)

CAD 0.05B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.04 (0.09%)

USD 1.25M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.04 (0.09%)

USD 1.25M
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.41 (+0.09%)

USD 0.09B
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

-0.02 (0.09%)

USD 17.89B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

+0.16 (+0.09%)

CAD 0.63B
XLV Health Care Select Sector.. 0.00 % 0.13 %

+0.02 (+0.09%)

USD 40.87B
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

N/A

CAD 0.33B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

+0.12 (+0.09%)

CAD 0.01B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+4.75 (+0.09%)

USD 1.69B
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

+0.08 (+0.09%)

USD 2.25B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.28 (+0.09%)

USD 0.40B
XGDD:LSE Xtrackers - Stoxx Global .. 0.00 % 0.00 %

+0.24 (+0.09%)

USD 0.58B
XGSD:LSE Xtrackers Stoxx Global Se.. 0.00 % 0.00 %

+12.00 (+0.09%)

USD 0.58B
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+28.75 (+0.09%)

USD 1.01B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.35 (+0.09%)

USD 1.01B
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.08 (+0.09%)

USD 2.09B
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+0.42 (+0.09%)

USD 1.01B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.35 (+0.09%)

USD 0.36B
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.09 (+0.09%)

USD 2.05B
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.45 (+0.09%)

USD 1.01B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.32 (+0.09%)

USD 0.36B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

+0.49 (+0.09%)

USD 1.27B
ANEW ProShares MSCI Transforma.. 0.00 % 0.00 %

+0.16 (+0.09%)

USD 8.05M
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

+0.05 (+0.09%)

N/A
FUD-A:CA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.26% 19% F 6% D-
Dividend Return 0.44% 100% F 31% F
Total Return -0.82% 19% F 7% C-
Trailing 12 Months  
Capital Gain 20.42% 62% D 94% A
Dividend Return 1.96% 67% D+ 37% F
Total Return 22.37% 62% D 94% A
Trailing 5 Years  
Capital Gain 81.27% 36% F 91% A-
Dividend Return 13.10% 71% C- 46% F
Total Return 94.37% 55% F 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 13.62% 38% F 86% B+
Dividend Return 15.95% 38% F 86% B+
Total Return 2.33% 100% F 47% F
Risk Return Profile  
Volatility (Standard Deviation) 19.34% 69% C- 37% F
Risk Adjusted Return 82.47% 46% F 76% C+
Market Capitalization 56.45B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 43.70 13% 3%
Price/Book Ratio 4.10 60% 17%
Price / Cash Flow Ratio 5.10 50% 21%
Price/Free Cash Flow Ratio 25.51 43% 20%
Management Effectiveness  
Return on Equity 2.87% 38% 31%
Return on Invested Capital 6.25% 44% 38%
Return on Assets 1.23% 44% 37%
Debt to Equity Ratio 76.25% 57% 48%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.